Gallagher Neil
SEC CIK 1972849 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc | Pres, Head of R, D | 85.1K | — | $71.6K | 3 | 2024-02-07 | 2025-02-10 |
Most active insiders at SNDX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Metzger Michael A | CEO, Dir | — | $1.43M |
| 2 | Botwood Nicholas A.J. | CMO, Head of R, D | — | $1.18M |
| 3 | Goldan Keith A. | CFO | — | $137.0K |
| 4 | Rizo Aleksandra | Dir | — | — |
| 5 | Jarrett Jennifer | Dir | — | — |
| 6 | Huber Martin H. Jr. | Dir | — | — |
| 7 | Legault Pierre | Dir | — | — |
| 8 | Katkin Keith | Dir | — | — |
| 9 | Podlesak Dennis | Dir | — | — |
Gallagher Neil made no open-market trades at SNDX in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-12 | 2025-02-10 | SNDX | Syndax Pharmaceuticals Inc | Gallagher Neil | Pres, Head of R, D | S - Sale | $15.50 | -4,618 | 85.1K | -5% | -$71.6K | |
| DM | 2025-02-07 | 2025-02-05 | SNDX | Syndax Pharmaceuticals Inc | Gallagher Neil | Pres, Head of R, D | A - Grant | $0.00 | +41.9K | 66.3K | +172% | $0 |
| DM | 2024-02-09 | 2024-02-07 | SNDX | Syndax Pharmaceuticals Inc | Gallagher Neil | Pres, Head of R, D | A - Grant | $0.00 | +47.8K | 47.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations